Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

BACKGROUND: Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces symptoms and the need for pharmacotherapy but has also been shown to have disease-mod...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Allergy Asthma Clin Immunol
Prif Awduron: Kim, Harold, Waserman, Susan, Hébert, Jacques, Blaiss, Michael, Nelson, Harold, Creticos, Peter, Kaur, Amarjot, Maloney, Jennifer, Li, Ziliang, Nolte, Hendrik
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2014
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363352/
https://ncbi.nlm.nih.gov/pubmed/25788949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-10-55
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg